Atlas Trials

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

Clinical trial NCT04332588 · RECRUITING

Trial details

NCT number
NCT04332588
Sponsor
University of Alabama at Birmingham
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2022-03-25
Primary completion
2027-08-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.